Organization
Pfizer Inc, Sollentuna, Sweden
1 abstract
Abstract
AGE-BASED (<65 VS ≥65 YEARS) INCIDENCE OF INFECTIONS AND SERIOUS INFECTIONS IN TOFACITINIB-, ADALIMUMAB- AND PLACEBO-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, PHASE 3 AND PHASE 3B/4 TOFACITINIB STUDIESOrg: Pfizer Inc, Montreal, QC, Canada, Pfizer Inc, Sollentuna, Sweden, Pfizer Inc, Groton, CT, United States of America, Pfizer Inc, Peapack, NJ, United States of America, Pfizer Inc, Collegeville, PA, United States of America,